
Glaukos Corporation (GKOS)
NYSE
The current GKOS market cap is 5.53B. The company's latest EPS is USD -2.5876 and P/E is -37.77.
Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 82.37M | 85.62M | 95.69M | 96.67M | 105.5M |
Operating Income | -38.62M | -39.07M | -29.97M | -24.66M | -28.67M |
Net Income | -36.78M | -40.84M | -50.55M | -21.41M | -33.58M |
Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 224.96M | 294.01M | 282.86M | 314.71M | 383.48M |
Operating Income | -123.55M | -62.87M | -113.21M | -128.7M | -122.37M |
Net Income | -120.35M | -49.59M | -100.1M | -134.66M | -146.37M |
Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 940.41M | 933.34M | 919.68M | 926.54M | 974.76M |
Total Liabilities | 478.65M | 482.61M | 254.52M | 258.03M | 207.83M |
Total Equity | 461.77M | 450.73M | 665.16M | 668.51M | 766.93M |
Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 1.01B | 1.05B | 1B | 940.41M | 974.76M |
Total Liabilities | 338.05M | 462.55M | 472.38M | 478.65M | 207.83M |
Total Equity | 667.45M | 587.15M | 530.01M | 461.77M | 766.93M |
Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -57.76M | -33.87M | -52.24M | -61.83M | -61.32M |
Investing | 14.1M | -29.38M | 5.48M | 36.04M | 47.83M |
Financing | 15.04M | 13.17M | 21.76M | 31.43M | 91.54M |
Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -22.99M | 24.71M | -33.08M | -57.76M | -61.32M |
Investing | -205.06M | -58.23M | 44.78M | 14.1M | 47.83M |
Financing | 262.54M | 39.26M | 6.25M | 15.04M | 91.54M |
Market Cap | 5.53B |
Price to Earnings Ratio | -37.77 |
Price to Sales Ratio | 14.42 |
Price to Cash Ratio | 32.59 |
Price to Book Ratio | 7.21 |
Dividend Yield | - |
Shares Outstanding | 56.57M |
Average Volume (1 week) | 1.46M |
Average Volume (1 Month) | 1.27M |
52 Week Change | 12.09% |
52 Week High | 161.78 |
52 Week Low | 84.08 |
Spread (Intraday) | 5.16 (5.1%) |
Company Name | Glaukos Corporation |
Address |
1201 north market st fl wilmington, delaware 19801 |
Website | https://www.glaukos.com |
Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.